Tilray Brands Inc
NASDAQ:TLRY

Watchlist Manager
Tilray Brands Inc Logo
Tilray Brands Inc
NASDAQ:TLRY
Watchlist
Price: 1.41 USD -1.4%
Market Cap: 1.3B USD
Have any thoughts about
Tilray Brands Inc?
Write Note

Tilray Brands Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tilray Brands Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Tilray Brands Inc
NASDAQ:TLRY
Revenue
$788.9m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Revenue
$87.7B
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Revenue
$47.4B
CAGR 3-Years
1%
CAGR 5-Years
14%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Revenue
$60.1B
CAGR 3-Years
-4%
CAGR 5-Years
14%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Revenue
$63.2B
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Revenue
$40.9B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
7%
No Stocks Found

Tilray Brands Inc
Revenue Breakdown

Breakdown by Geography
Tilray Brands Inc

Total Revenue: 788.9m USD
100%
EMEA: 296.5m USD
37.6%
Canada: 243.7m USD
30.9%
United States: 233.1m USD
29.6%
Rest Of World: 15.6m USD
2%
Show More
Show Less

Breakdown by Segments
Tilray Brands Inc

Total Revenue: 788.9m USD
100%
Cannabis Segment: 272.8m USD
34.6%
Tilray Pharma Segment: 258.7m USD
32.8%
Beverage Alcohol Business: 202.1m USD
25.6%
Wellness Business: 55.3m USD
7%
Show More
Show Less

Tilray Brands Inc
Glance View

Market Cap
1.2B USD
Industry
Pharmaceuticals

Tilray Brands Inc. emerged on the cannabis scene as a formidable player, carving its niche in a highly volatile yet promising industry. Founded amidst the wave of cannabis legalization sweeping across North America, Tilray quickly became one of the first companies to go public on a major U.S. stock exchange. The company has built its reputation through strategic mergers and acquisitions, most notably its merger with Aphria in 2021, which positioned it as a global leader with comprehensive scale and operational efficiencies. Headquartered in Canada, Tilray has extended its reach with production and distribution facilities not only in the Americas but also across Europe and Australia, capitalizing on the burgeoning medical cannabis market and expanding adult-use sectors. Its array of products spans from dried cannabis flowers and oils to edibles and beverages, catering to diverse consumer needs. Tilray's core business model hinges on a vertically integrated approach, which enables it to oversee the entire supply chain – from cultivation and processing to distribution and sales. This model not only enhances product consistency and quality control but also improves margins by reducing dependency on third-party suppliers. The company primarily generates revenue through its extensive portfolio of brand offerings, including medical-grade products for healthcare providers and recreational products for consumers. Additionally, it has embraced strategic partnerships and diversified into the consumer health and wellness space, venturing into hemp-based foods and alcoholic beverages. By leveraging its global infrastructure and brand strength, Tilray continues to navigate the evolving regulatory landscapes, aiming to capture a significant share of the cannabis industry's projected growth.

TLRY Intrinsic Value
1.17 USD
Overvaluation 17%
Intrinsic Value
Price

See Also

What is Tilray Brands Inc's Revenue?
Revenue
788.9m USD

Based on the financial report for May 31, 2024, Tilray Brands Inc's Revenue amounts to 788.9m USD.

What is Tilray Brands Inc's Revenue growth rate?
Revenue CAGR 3Y
15%

Over the last year, the Revenue growth was 26%. The average annual Revenue growth rates for Tilray Brands Inc have been 15% over the past three years .

Back to Top